Home The Word Brain My Amedeo FAQ Privacy About   


C49 + CC Journal Club

For more information, please refer to our special emails from April 13 and May 19.


  Chronic Heart Failure

  Free Subscription


Articles published in J Cardiol

Retrieve available abstracts of 84 articles:
HTML format



Single Articles


    May 2025
  1. EGAMI Y, Kobayashi N, Sugino A, Abe M, et al
    Impact of Sinus Rhythm Maintenance After Repeat Catheter Ablation on Clinical Outcomes in Heart Failure with Preserved Ejection Fraction.
    J Cardiol. 2025 May 20:S0914-5087(25)00127-3. doi: 10.1016/j.jjcc.2025.
    PubMed     Abstract available


  2. SHIRAKABE A, Matsushita M, Shigihara S, Nishigoori S, et al
    Age-specific differences of Impella support in Japanese patients: The Japanese Registry for Percutaneous Ventricular Assist Device (J-PVAD) registry analysis on outcomes and adverse events.
    J Cardiol. 2025;85:343-351.
    PubMed     Abstract available


  3. VOLK MC, Mirzai S, Persits I, Sarnaik KS, et al
    Associations of adipose tissue depots with cardiac resynchronization therapy response and clinical outcomes: A CRT-HF Clinic substudy.
    J Cardiol. 2025;85:421-423.
    PubMed     Abstract available


    April 2025
  4. SHIMOYA Y, Tani Y, Yuasa N, Kagami K, et al
    Pathophysiologic and prognostic relevance of mid-upper arm circumference index in heart failure with preserved ejection fraction.
    J Cardiol. 2025 Apr 28:S0914-5087(25)00107-8. doi: 10.1016/j.jjcc.2025.
    PubMed     Abstract available


  5. IBRAHIM M
    Letter to the editor on association between complementary use of Goreisan and heart failure readmission: A nationwide propensity score-matched study.
    J Cardiol. 2025 Apr 24:S0914-5087(25)00104-2. doi: 10.1016/j.jjcc.2025.
    PubMed    


  6. SAITO Y, Kagiyama N, Harada T, Kaneko T, et al
    An evidence-based tool for screening for heart failure with preserved ejection fraction in primary care: The BREATH(2) score.
    J Cardiol. 2025 Apr 3:S0914-5087(25)00098-X. doi: 10.1016/j.jjcc.2025.
    PubMed     Abstract available


    March 2025
  7. OKAJIMA T, Ishikawa S, Uemura Y, Ozaki Y, et al
    Efficacy of sodium-glucose cotransporter 2 inhibitors on preventing atrial arrhythmia recurrences after atrial fibrillation ablation in patients with heart failure.
    J Cardiol. 2025 Mar 19:S0914-5087(25)00088-7. doi: 10.1016/j.jjcc.2025.
    PubMed     Abstract available


  8. TSUCHIDA K, Tanabe N, Tanaka K, Ozeki K, et al
    Twelve-year trends of hospitalizations and survival of acute decompensated heart failure: Data from a regional tertiary center.
    J Cardiol. 2025 Mar 19:S0914-5087(25)00089-9. doi: 10.1016/j.jjcc.2025.
    PubMed     Abstract available


  9. YAMAMOTO A, Nagao M, Nomoto M, Inoue A, et al
    Prediction of cardiac allograft vasculopathy using splenic switch-off on myocardial PET.
    J Cardiol. 2025;85:260-262.
    PubMed     Abstract available


    February 2025
  10. LI M, Zhang J, Hu Y, Zhang Y, et al
    Cognitive impairment in patients with heart failure: Physiopathology, clinical implications, and therapeutic considerations.
    J Cardiol. 2025 Feb 12:S0914-5087(25)00056-5. doi: 10.1016/j.jjcc.2025.
    PubMed     Abstract available


  11. HOSODA Y, Goda A, Yanagisawa Y, Miura Y, et al
    Prediction of left ventricular reverse remodeling in patients with heart failure with reduced ejection fraction using cardiopulmonary exercise testing.
    J Cardiol. 2025 Feb 5:S0914-5087(25)00021-8. doi: 10.1016/j.jjcc.2025.
    PubMed     Abstract available


  12. SIDDIQI AK, Shahzad M, Kumar A, Ahmed M, et al
    The efficacy of inspiratory muscle training in improving clinical outcomes in heart failure patients: An updated systematic review and Meta-analysis.
    J Cardiol. 2025 Feb 3:S0914-5087(25)00016-4. doi: 10.1016/j.jjcc.2025.
    PubMed     Abstract available


  13. HAMAGUCHI K, Sakakura K, Jinnouchi H, Taniguchi Y, et al
    Comparison of clinical outcomes between proximal and non-proximal right coronary artery occlusion in patients with inferior ST-segment elevation myocardial infarction.
    J Cardiol. 2025;85:88-95.
    PubMed     Abstract available


    January 2025
  14. BASILE P, Guaricci AI
    Author's reply to the Letter to the Editor "How to demonstrate the causal relationship between sodium-glucose cotransporter 2 receptor and prevention of ventricular arrhythmia in heart failure cohorts".
    J Cardiol. 2025 Jan 31:S0914-5087(25)00012-7. doi: 10.1016/j.jjcc.2025.
    PubMed    


  15. HORIUCHI Y, Matsue Y, Wettersten N, Oishi S, et al
    Racial differences in diuretic therapy, B-type natriuretic peptide values, and prognosis in acute heart failure.
    J Cardiol. 2025 Jan 30:S0914-5087(25)00013-9. doi: 10.1016/j.jjcc.2025.
    PubMed     Abstract available


  16. AKAMA Y, Matsue Y, Maeda D, Dotare T, et al
    Prognostic values of proteinuria in patients with acute heart failure.
    J Cardiol. 2025 Jan 28:S0914-5087(25)00010-3. doi: 10.1016/j.jjcc.2025.
    PubMed     Abstract available


  17. KATAOKA N, Imamura T
    How to demonstrate the causal relationship between sodium-glucose cotransporter 2 receptor and prevention of ventricular arrhythmia in heart failure cohorts.
    J Cardiol. 2025 Jan 20:S0914-5087(25)00006-1. doi: 10.1016/j.jjcc.2025.
    PubMed    


  18. YUASA N, Ubukata S, Takayanagi R, Yamashita E, et al
    Collaboration between dyspnea clinic and primary care physicians to identify heart failure with preserved ejection fraction in the community: Results from the Maebashi City HF project.
    J Cardiol. 2025 Jan 14:S0914-5087(25)00001-2. doi: 10.1016/j.jjcc.2025.
    PubMed     Abstract available


  19. PASCOE MA, Kolodziej A, Birks EJ, Vaidya G, et al
    Using electronic medical records to identify patients at risk for underlying cardiac amyloidosis.
    J Cardiol. 2025;85:43-44.
    PubMed     Abstract available


    December 2024
  20. SUZUKI Y, Kaneko H, Okada A, Fujiu K, et al
    BP classification using the 2017 ACC/AHA BP guidelines with risk of cardiovascular events in older individuals.
    J Cardiol. 2024;84:394-403.
    PubMed     Abstract available


    November 2024
  21. RAJAKUMAR HK
    Telemonitoring in heart failure care: Does feasibility equate to clinical benefit?
    J Cardiol. 2024 Nov 26:S0914-5087(24)00219-3. doi: 10.1016/j.jjcc.2024.
    PubMed    


  22. RMILAH AA, Abdelhafez M, Balla AK, Ahmad S, et al
    Outcomes of mitral TEER in non-responders to cardiac resynchronization therapy: A systematic review and meta-analysis.
    J Cardiol. 2024;84:317-325.
    PubMed     Abstract available


  23. ONODA H, Imamura T, Ueno H, Oshima A, et al
    Paradoxical prognostic impact of severe aortic stenosis following trans-catheter aortic valve implantation.
    J Cardiol. 2024;84:311-316.
    PubMed     Abstract available


    October 2024
  24. KOMURO J, Kaneko H, Suzuki Y, Okada A, et al
    Unawareness of being prescribed medications for diabetes and incident cardiovascular disease.
    J Cardiol. 2024;84:294-299.
    PubMed     Abstract available


  25. MIYAKE M, Izumi C, Watanabe H, Ozasa N, et al
    Prognostic value of E/e' ratio and its change over time in ST-segment elevation myocardial infarction with preserved left ventricular ejection fraction in the reperfusion era.
    J Cardiol. 2024;84:253-259.
    PubMed     Abstract available


    September 2024
  26. ISOGAI T, Morita K, Okada A, Michihata N, et al
    Association between complementary use of Goreisan (a Japanese herbal Kampo medicine) and heart failure readmission: A Nationwide propensity score-matched study.
    J Cardiol. 2024 Sep 26:S0914-5087(24)00182-5. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available


  27. SUETA D, Araki S, Usuku H, Fujisaki T, et al
    Clinical outcomes of patients from older community hospitalized for heart failure in guideline-directed medical therapy era: Insights from the COMPASS-HF registry.
    J Cardiol. 2024 Sep 17:S0914-5087(24)00178-3. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available


  28. TSUTSUI H, Momomura SI, Saito Y, Ito H, et al
    Incidence and risk factors of hypotension-related adverse events among Japanese patients with heart failure receiving sacubitril/valsartan or enalapril: Results from the PARALLEL-HF study.
    J Cardiol. 2024 Sep 14:S0914-5087(24)00174-6. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available


  29. BASILE P, Monitillo F, Santoro D, Falco G, et al
    Impact on ventricular arrhythmic burden of SGLT2 inhibitors in patients with chronic heart failure evaluated with cardiac implantable electronic device monitoring.
    J Cardiol. 2024 Sep 13:S0914-5087(24)00177-1. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available


  30. MIYAZAKI Y, Ishibashi K, Ueda N, Oka S, et al
    Evaluation of synchronized left ventricular pacing rate over biventricular pacing in cardiac resynchronization therapy.
    J Cardiol. 2024;84:165-169.
    PubMed     Abstract available


    August 2024
  31. MISUMI K, Matsue Y, Nogi K, Fujimoto Y, et al
    Usefulness of hypochloremia at the time of discharge to predict prognosis in patients with chronic heart failure after hospitalization.
    J Cardiol. 2024 Aug 30:S0914-5087(24)00171-0. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available


  32. HASHEM A, Khalouf A, Mohamed MS, Adra S, et al
    Early vs. Late Transcatheter Aortic Valve Replacement in Acute Heart Failure Hospitalizations: A Comparative Nationwide Analysis.
    J Cardiol. 2024 Aug 16:S0914-5087(24)00159-X. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available


  33. MATSUMOTO S, McMurray JJV, Nasu T, Ishii S, et al
    Relevant adverse events and drug discontinuation of sacubitril/valsartan in a real-world Japanese cohort: REVIEW-HF registry.
    J Cardiol. 2024;84:133-140.
    PubMed     Abstract available


  34. MATSUSHITA H, Saku K, Nishikawa T, Unoki T, et al
    Impact of right ventricular and pulmonary vascular characteristics on Impella hemodynamic support in biventricular heart failure: A simulation study.
    J Cardiol. 2024 Aug 1:S0914-5087(24)00145-X. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available


    July 2024
  35. INOUE K, Smiseth OA
    Left atrium as key player and essential biomarker in heart failure.
    J Cardiol. 2024 Jul 29:S0914-5087(24)00135-7. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available



  36. Urinary sodium excretion for loop diuretic response in acute heart failure.
    J Cardiol. 2024 Jul 5:S0914-5087(24)00129-1. doi: 10.1016/j.jjcc.2024.
    PubMed    


    June 2024
  37. OKADA T, Takagi W, Miyoshi T, Oka A, et al
    Efficacy and safety of intravenous versus oral tolvaptan in the acute phase of acute decompensated heart failure.
    J Cardiol. 2024 Jun 23:S0914-5087(24)00125-4. doi: 10.1016/j.jjcc.2024.
    PubMed    


  38. NODA T, Kamiya K, Hamazaki N, Nozaki K, et al
    Effect of change in hepato-renal function and cardiac rehabilitation on mortality in patients with heart failure.
    J Cardiol. 2024 Jun 23:S0914-5087(24)00123-0. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available


  39. HORIUCHI Y, Wettersten N
    Treatment strategies for diuretic resistance in patients with heart failure.
    J Cardiol. 2024 Jun 22:S0914-5087(24)00122-9. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available


  40. ITO H, Fujimoto N, Mori H, Kirii Y, et al
    Unveiling the new era of heart failure management using mobile health: A pilot study of "heart sign" focusing on user experience and quality of life.
    J Cardiol. 2024 Jun 11:S0914-5087(24)00103-5. doi: 10.1016/j.jjcc.2024.
    PubMed    


  41. SHIBATA T, Mizuno A, Ohmori T, Oishi S, et al
    Public awareness of palliative care for heart failure in Japan: A cross-sectional study.
    J Cardiol. 2024 Jun 3:S0914-5087(24)00101-1. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available


  42. SHIINA Y, Nagao M, Itatani K, Shimada E, et al
    4D flow MRI-derived energy loss and RV workload in adults with tetralogy of Fallot.
    J Cardiol. 2024;83:382-389.
    PubMed     Abstract available


    May 2024
  43. VLACHAKIS PK, Tsiachris D, Doundoulakis I, Tsioufis P, et al
    Therapeutic inertia in rhythm control strategies in hospitalized patients with fibrillation: Insights from Hellenic Cardiorenal Morbidity Snapshot (HECMOS) study.
    J Cardiol. 2024;83:313-317.
    PubMed     Abstract available


  44. KAGIYAMA N, Kasai T, Murata N, Yamakawa N, et al
    Feasibility of self-measurement Telemonitoring using a handheld heart sound recorder in patients with heart failure - SELPH multicenter pilot study.
    J Cardiol. 2024 May 1:S0914-5087(24)00082-0. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available


    April 2024
  45. BUTTER L, Haase-Fielitz A, Zanker M, Becher G, et al
    Cluster analysis of volatile organic compounds - a pilot study in patients with severe acute decompensated heart failure.
    J Cardiol. 2024 Apr 13:S0914-5087(24)00062-5. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available


  46. MAKHOUL GW, Mustafa A, Wei C, Ling J, et al
    Heart failure - An unexplored risk factor for infective endocarditis after pacemaker implantation.
    J Cardiol. 2024 Apr 5:S0914-5087(24)00061-3. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available


  47. SAITO S, Okubo S, Matsuoka T, Hirota S, et al
    Impella - Current issues and future expectations for the percutaneous, microaxial flow left ventricular assist device.
    J Cardiol. 2024;83:228-235.
    PubMed     Abstract available


    March 2024
  48. OHIRA T, Eguchi E, Hayashi F, Kinuta M, et al
    Epidemiology of cardiovascular disease in Japan: An overview study.
    J Cardiol. 2024;83:191-200.
    PubMed     Abstract available


  49. ONODA H, Imamura T, Ueno H, Oshima A, et al
    Prognostic impact of elevated erythropoietin levels in patients with severe aortic stenosis receiving trans-catheter aortic valve implantation.
    J Cardiol. 2024;83:149-154.
    PubMed     Abstract available


    February 2024
  50. SUGAWARA M, Kondo Y, Ryuzaki S, Yoshino Y, et al
    Long-term prognosis and prognostic factors after primary prophylactic implantable cardioverter-defibrillator therapy.
    J Cardiol. 2024 Feb 19:S0914-5087(24)00024-8. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available


  51. YAKU H, Fudim M, Shah SJ
    Role of splanchnic circulation in the pathogenesis of heart failure: State-of-the-art review.
    J Cardiol. 2024 Feb 16:S0914-5087(24)00022-4. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available


  52. SHIBATA T, Matsumoto S, Muramoto T, Matsukawa M, et al
    Comparison of the treatment status of patients with acute heart failure before and during the COVID-19 pandemic - Observational cohort study using Japanese administrative data.
    J Cardiol. 2024 Feb 2:S0914-5087(24)00011-X. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available


    December 2023
  53. SATO K, Kamiya K, Hamazaki N, Nozaki K, et al
    Association of sarcopenia defined by different skeletal muscle mass measurements with prognosis and quality of life in older patients with heart failure.
    J Cardiol. 2023 Dec 20:S0914-5087(23)00305-2. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available


  54. TOMSIC A, Meucci MC, de Jong AR, Braun J, et al
    Mitral regurgitation in atrial fibrillation: Is a simple repair enough to tackle a complex problem?
    J Cardiol. 2023 Dec 14:S0914-5087(23)00295-2. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available


    November 2023
  55. HEIDENREICH P
    Heart failure management guidelines: New recommendations and implementation.
    J Cardiol. 2023 Nov 8:S0914-5087(23)00271-X. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available


    October 2023
  56. UCHIYAMA S, Toki M, Kitai T, Yoshioka K, et al
    Dynamic changes in echocardiographic parameters in acute decompensated heart failure: REALITY-ECHO.
    J Cardiol. 2023 Oct 24:S0914-5087(23)00268-X. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available


  57. POL T, Karlstrom P, Lund LH
    Heart failure registries - Future directions.
    J Cardiol. 2023 Oct 14:S0914-5087(23)00257-5. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available


  58. SI J, Ding Z, Hu Y, Zhang X, et al
    Predictors and prognostic implications of left ventricular ejection fraction trajectory improvement in the spectrum of heart failure with reduced and mildly reduced ejection fraction.
    J Cardiol. 2023 Oct 5:S0914-5087(23)00242-3. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available


  59. OKAMURA M, Kataoka Y, Taito S, Fujiwara T, et al
    Early mobilization for acute heart failure: A scoping and a systematic review.
    J Cardiol. 2023 Oct 3:S0914-5087(23)00239-3. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available


    September 2023
  60. SEO M, Watanabe T, Yamada T, Morita T, et al
    The clinical relevance of mild cognitive impairment in acute heart failure: A comparison with cognitive impairment.
    J Cardiol. 2023 Sep 6:S0914-5087(23)00222-8. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available


  61. MATSUDA H, Kuragaichi T, Sato Y
    Investigating the seasonal variation of heart failure hospitalizations and in-hospital mortality risks in Japan using a nationwide database.
    J Cardiol. 2023 Sep 2:S0914-5087(23)00219-8. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available


    August 2023
  62. HORIBE H, Ando K, Maekawa Y, Narisawa M, et al
    The association of serum adiponectin level with activities of daily living in hospitalized elderly patients with heart failure.
    J Cardiol. 2023 Aug 15:S0914-5087(23)00202-2. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available


  63. HARRISON NE, Ehrman R, Collins S, Desai AA, et al
    The prognostic value of improving congestion on lung ultrasound during treatment for acute heart failure differs based on patient characteristics at admission.
    J Cardiol. 2023 Aug 12:S0914-5087(23)00190-9. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available


  64. ICHIHARA YK, Kohsaka S, Kisanuki M, Sandhu ATS, et al
    Implementation of evidence-based heart failure management: Regional variations between Japan and the USA.
    J Cardiol. 2023 Aug 3:S0914-5087(23)00185-5. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available


  65. KLARSKOV VR, Ladefoged BT, Pedersen ALD, Hartig-Andreasen C, et al
    Clinical characteristics and prognostic implications of orthopedic ligament disorders in patients with wild-type transthyretin amyloidosis cardiomyopathy.
    J Cardiol. 2023;82:122-127.
    PubMed     Abstract available


    July 2023
  66. YUASA N, Obokata M, Harada T, Kagami K, et al
    Characterization and Prognostic Importance of Chronotropic Incompetence in Heart Failure with Preserved Ejection Fraction.
    J Cardiol. 2023 Jul 5:S0914-5087(23)00159-4. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available


  67. FERREIRA JP, Zannad F, Kiernan MS, Konstam MA, et al
    High- versus low-dose losartan and uric acid: An analysis from HEAAL.
    J Cardiol. 2023;82:57-61.
    PubMed     Abstract available


  68. UGATA Y, Hayashi T, Yamamoto S, Fujita H, et al
    Impact of Q wave in synthesized V7-9 lead on long-term outcomes after cardiac resynchronization therapy.
    J Cardiol. 2023;82:51-56.
    PubMed     Abstract available


  69. MATSUURA K, Kumamaru H, Kohsaka S, Kanda T, et al
    Impact of concomitant mitral regurgitation during transcatheter aortic valve replacement on 1-year survival outcomes.
    J Cardiol. 2023;82:16-21.
    PubMed     Abstract available


  70. NAKAGAWA S, Takahama H, Hoshino K, Yanagi Y, et al
    Prevalence and predictive factors for clinical outcomes of isolated functional tricuspid regurgitation.
    J Cardiol. 2023;82:8-15.
    PubMed     Abstract available


    June 2023
  71. BHATIA K, Sabharwal B, Gupta K, Lopez PD, et al
    Clinical outcomes of intravenous Iron therapy in patients with heart failure and Iron deficiency: Meta-analysis and trial sequential analysis of randomized clinical trials.
    J Cardiol. 2023 Jun 26:S0914-5087(23)00157-0. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available


  72. GUDENKAUF B, Shaya G, Mukherjee M, Michos ED, et al
    Insulin resistance is associated with subclinical myocardial dysfunction and reduced functional capacity in heart failure with preserved ejection fraction.
    J Cardiol. 2023 Jun 24:S0914-5087(23)00153-3. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available


  73. HUANG HT, Ko SL, Wang CY, Lo HC, et al
    Risk stratification for worsening renal function and renal decline in heart failure patients with reduced ejection fraction after sacubitril/valsartan treatment.
    J Cardiol. 2023 Jun 7:S0914-5087(23)00129-6. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available


    May 2023
  74. NOGI K, Yamamoto R, Ueda T, Nogi M, et al
    Derivation and validation of a clinical predictive model of NT-proBNP >/=125 pg/mL to detect pre-heart failure.
    J Cardiol. 2023 May 27:S0914-5087(23)00126-0. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available


  75. KATAOKA N, Imamura T
    Prognostic impact of xanthine oxidoreductase activity in patients with heart failure and atrial fibrillation.
    J Cardiol. 2023 May 24:S0914-5087(23)00115-6. doi: 10.1016/j.jjcc.2023.
    PubMed    


  76. TOGASHI I, Sato T
    Conduction system pacing: Current status and prospects.
    J Cardiol. 2023;81:413-419.
    PubMed     Abstract available


  77. SHIBASAKI I, Otani N, Saito S, Ogawa H, et al
    Overview of mechanical circulatory support for the management of post-myocardial infarction ventricular septal rupture.
    J Cardiol. 2023;81:491-497.
    PubMed     Abstract available


    April 2023
  78. TAMAKI Y, Iwano H, Murayama M, Ishizaka S, et al
    Application of an echocardiographic scoring system of left ventricular filling pressure to diagnose acute heart failure in patients complaining dyspnea.
    J Cardiol. 2023 Apr 28:S0914-5087(23)00100-4. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available


  79. SEGEV A, Maor E, Goldenfeld M, Itelman E, et al
    Atrial fibrillation in young hospitalized patients: clinical characteristics, predictors of new onset, and outcomes.
    J Cardiol. 2023 Apr 26:S0914-5087(23)00096-5. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available


  80. JOKI Y, Konishi H, Takasu K, Minamino T, et al
    Tofogliflozin, a sodium-glucose cotransporter 2 inhibitor, improves pulmonary vascular remodeling due to left heart disease in mice.
    J Cardiol. 2023;81:347-355.
    PubMed     Abstract available


  81. SHINKAWA T, Ichihara Y, Saito S, Ishido M, et al
    Ventricular assist device for end-stage adult congenital heart disease patients: Current status.
    J Cardiol. 2023;81:378-384.
    PubMed     Abstract available


    March 2023
  82. KINOSHITA M, Saito M, Inoue K, Nakagawa H, et al
    Role of the right ventricular contractile reserve during low-load exercise in predicting heart failure readmission.
    J Cardiol. 2023 Mar 8:S0914-5087(23)00049-7. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available


    February 2023
  83. MISUMI K, Matsue Y, Nogi K, Fujimoto Y, et al
    Derivation and validation of a machine learning-based risk prediction model in patients with acute heart failure.
    J Cardiol. 2023 Feb 27:S0914-5087(23)00045-X. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available


  84. TSUTSUI H, Sakamaki H, Momomura SI, Sakata Y, et al
    Cost-effectiveness analysis of Empagliflozin in patients with heart failure with reduced ejection fraction in Japan based on the EMPEROR-reduced trial.
    J Cardiol. 2023 Feb 27:S0914-5087(23)00046-1. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.